Senescent cells secrete factors known as the senescence-associated secretory phenotype (SASP), which can contribute to chronic inflammation and create a microenvironment favorable for cancer progression
Journal of Critical Care
It also enhances the action of major growth factors such as epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), and transforming growth factor- (TGF-) (Kim and Kim 2017)
Youre not just a chartyoure a person with goals for recovery
Based on the working hypothesis of P-gp-dependent collateral sensitivity [14,15,16,17], we examined the ability of tamoxifen as a collateral sensitivity drug for two reasons: a) tamoxifen has been previously shown to activate P-gp ATPase at clinically achievable concentration (46 M) [20, 21], and b) tamoxifen is widely used in the treatment of estrogen receptor-positive breast cancer [22]
Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031